AptarGroup Gains After 4Q Results, Buyback Plan

Dow Jones
02/07
 

By Josh Beckerman

 

Shares of AptarGroup rose after the company reported fourth-quarter results and announced a $600 million buyback authorization.

The stock was recently up 7.3%, to $133.02, but has fallen about 7% over the past 52 weeks.

AptarGroup, which provides dosing, dispensing and protection technologies for drugs and consumer products, said sales rose 14%, to $962.7 million. The prescription division benefited from strong demand for systemic nasal drug delivery used for central nervous system therapies and pain management, while the injectables division was helped by growth in GLP-1 elastomeric components.

Adjusted earnings per share fell to $1.25 from $1.62. In October, the company said, in the short term, it expected to face tough comparisons from a one-time naloxone ramp-up and said it expected fourth-quarter adjusted earnings of $1.20 to $1.28 a share. AptarGroup said Thursday that it expects $1.13 to $1.21 for the first quarter.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

February 06, 2026 13:32 ET (18:32 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10